BioSpace News Archive

BioAtla, Inc. today announced it will host a virtual R&D Day on Wednesday, December 13, 2023 at 10:00 AM ET.

Bionomics Limited (Nasdaq: BNOX) (Bionomics or Company) today announced the presentation of data on the psychometric validity and reliability of SUDS as an outcome measure in assessing anxiety in SAD clinical trials at the 2023 American College of Neuropsychopharmacology Annual Meeting taking place December 3 – 6 in Tampa, Florida.

Curis, Inc. today announced that the Company along with its collaborative partners will be presenting three posters at the upcoming 65th ASH Annual Meeting and Exposition (ASH 2025).

Alnylam Pharmaceuticals, Inc. announced today that it will webcast its upcoming virtual R&D Day event on the Investors section of the Company’s website, www.alnylam.com, on Wednesday, December 13, 2023 at 8:30 am ET.

TeselaGen Biotechnology, Inc., a leader in the field of biological design and process automation, announces its DNA manufacturing spin-off, Built Biotechnologies, Inc. (“Built”).

Bionano Genomics, Inc. (Nasdaq: BNGO) today announced that the American Society of Hematology (ASH) Annual Meeting and Exposition 2023 will feature a broad range of content covering OGM’s utility for research in areas including myeloid cancer, hematological malignancy, leukemia and blood disorders.

Empress Therapeutics today announced that Virginia Finnerty-Brooks has been appointed Chief Business Officer (CBO).

Alentis Therapeutics today announced that Rizwan Velji has been appointed Chief Business Officer (CBO).

Biofidelity today announced the commercial launch of its ASPYRE ® -Lung RUO reagent product.

Gallant Therapeutics announced the launch of a pivotal study to evaluate the safety and efficacy of its novel allogeneic stem cell therapy candidate to support FDA conditional approval in cats with refractory feline chronic gingivostomatitis, the JEDI study.